STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

Why only for healthcare professionals?

The content on these information pages is directed solely at you if you are a doctor, nurse, or pharmacist, as it concerns treatment with prescription medicines.

Please confirm that you are a healthcare professional (healthcare assistant, nurse, doctor, psychologist, or other licensed healthcare professional).

Back to main page

Confirm and continue

Press release
November 27, 2025

Yazen named best in weight loss treatment for its proven results

Yazen wins “Weight Loss Treatment of the Year 2025 award” for its innovative, evidence-based care helping over 47,000 patients achieve sustainable weight loss.

Weightloss of the Year diploma

Yazen Wins the Weight Loss Treatment of the Year Award in Europe 2025

The digital healthcare provider Yazen has been awarded “Weight Loss Treatment of the Year in Europe 2025” by the international magazine Healthcare Business Review.


The award is presented to the organisation that best combines innovation, medical quality, and patient satisfaction in the field of weight loss treatment in Europe.

"We are glad to give Yazen the Weight Loss Treatment of the Year in Europe 2025 Award," said Alex D'souza, Managing Editor at Healthcare Business Review Magazine. "Its data-driven platform delivers safe, personalised care with real-world outcomes from over 40,000 patients, demonstrating sustainable weight loss and measurable improvements in long-term metabolic health."  
Fredrik Meurling, CEO and co-founder of Yazen said:
“This is fantastic recognition of the strength of our evidence-based care model. We’ve built a model where doctors, psychologists, dietitians, and health coaches work closely with each patient – often in combination with modern medications. It’s long-term care for a chronic disease.”.

So far, Yazen has helped over 47,000 patients lose more than 560 tons of weight – a success that reflects both the medical efficacy and the personalised support in the treatment.

“It's great to win awards like this, but what means the most is hearing every day from our patients about how we’re changing their lives. That’s what drives us,” concludes Fredrik Meurling.


About the award


The “Weight Loss Treatment of the Year in Europe 2025” award is presented by the international publication Healthcare Business Review to recognise organisations demonstrating exceptional quality and innovation in healthcare. Yazen received the award following a thorough evaluation by an expert panel consisting of leading decision-makers, industry professionals, and the editorial team.

Healthcare Business Review is an international business magazine that offers current industry news, insights from leading players and market analysis to decision-makers in the healthcare sector.

Read an interview with Fredrik Meurling in Healthcare Business Review.

For more information:


Fredrik Pallin, VP Public Relations via fredrik.pallin@yazen.com or +46 708 114 115.
+ local contact

More news

WOD26: Data Reveals Persistent Shame & Stigma Around Obesity Treatment

Ahead of World Obesity Day on 4 March, Yazen is sharing new findings from internal patient data, revealing that shame and stigma remain major barriers to obesity care — even as effective medical treatments become more widely available.

UK firms eye GLP-1 benefits to cut sick leave and boost performance.

UK employers are increasingly considering weight-loss support as part of employee benefits, as new Yazen patient data links GLP-1 treatment to reduced sick days and improved workplace performance.

Yazen achieved record-breaking growth in 2025, doubling its revenue.

In 2025, Yazen's revenue surged 87% to nearly €29.4 million, with gross profits doubling to €16.5 million. Now treating over 37,000 active patients across seven countries, the company is eyeing further expansion into two more markets in 2026. Despite an EBITDA of –€5.7 million due to heavy growth investment, Yazen remains a leader in European obesity care.